Research News From September 17, 2006
advertisement
- Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations. See also Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus, Drug Restores Insulin Secretion for Rare Type 1 Cases, and Molecular medicine comes to the rescue: Targeted therapy turns life around for child with neonatal diabetes. Parents of children who were diagnosed before 6 months of age should speak with their diabetes team about this research.
- Effect of Ramipril on the Incidence of Diabetes. The DREAM Trial Investigators. Full text available in PDF format. See also Angiotensin-Converting�Enzyme Inhibitors for Impaired Glucose Tolerance � Is There Still Hope?, EASD: ACE-Inhibitor Diabetes Prevention DREAM is Over, and Drug Can Prevent Diabetes in Many at High Risk, Study Suggests.
- Abstracts are available from the just completed EASD meeting.
- MRI Can Track Survival Of Pancreatic Islets After Transplantation.
- Extreme genetic risk for type 1A diabetes. Full text available in PDF format.
- Seasonal variation in the diagnosis of type 1 diabetes in south-east Sweden.
- Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection.
- Circulating antibodies to nephrin in patients with type 1 diabetes.
- The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients.
- Iodine status, thyroid function, thyroid volume and thyroid autoimmunity in patients with type 1 diabetes mellitus in an iodine-replete area.
- Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice.
- Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro.
- Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. Full text available in HTML and PDF formats.
- Little evidence for early programming of weight and insulin resistance for contemporary children: EarlyBird Diabetes Study report 19.
- Liraglutide, A Once-daily GLP-1 Analogue, Shows Potential To Change Course Of [Type 2] Diabetes.
